These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11147669)

  • 41. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.
    Kato S; Shimoda H; Ji RC; Miura M
    Anat Sci Int; 2006 Jun; 81(2):71-83. PubMed ID: 16800291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
    Yoon YS; Murayama T; Gravereaux E; Tkebuchava T; Silver M; Curry C; Wecker A; Kirchmair R; Hu CS; Kearney M; Ashare A; Jackson DG; Kubo H; Isner JM; Losordo DW
    J Clin Invest; 2003 Mar; 111(5):717-25. PubMed ID: 12618526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocyte growth factor promotes lymphatic vessel formation and function.
    Kajiya K; Hirakawa S; Ma B; Drinnenberg I; Detmar M
    EMBO J; 2005 Aug; 24(16):2885-95. PubMed ID: 16052207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lymphatic vasculature: recent progress and paradigms.
    Oliver G; Alitalo K
    Annu Rev Cell Dev Biol; 2005; 21():457-83. PubMed ID: 16212503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
    Mandriota SJ; Pepper MS
    J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.
    Kajiya K; Hirakawa S; Detmar M
    Am J Pathol; 2006 Oct; 169(4):1496-503. PubMed ID: 17003502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development.
    Eichten A; Hyun WC; Coussens LM
    Cancer Res; 2007 Jun; 67(11):5211-20. PubMed ID: 17545601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of tissue expansion on skin lymph flow and lymphatics: an experimental study in rabbits.
    Erçöçen AR; Yilmaz S; Can Z; Berk F; Kir M; Yenidünya S; Edali N; Ozbek MR
    Scand J Plast Reconstr Surg Hand Surg; 1998 Dec; 32(4):353-8. PubMed ID: 9862101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular biology and pathology of lymphangiogenesis.
    Karpanen T; Alitalo K
    Annu Rev Pathol; 2008; 3():367-97. PubMed ID: 18039141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
    Skobe M; Hamberg LM; Hawighorst T; Schirner M; Wolf GL; Alitalo K; Detmar M
    Am J Pathol; 2001 Sep; 159(3):893-903. PubMed ID: 11549582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.
    Achen MG; Stacker SA
    Int J Cancer; 2006 Oct; 119(8):1755-60. PubMed ID: 16557570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
    Hong YK; Lange-Asschenfeldt B; Velasco P; Hirakawa S; Kunstfeld R; Brown LF; Bohlen P; Senger DR; Detmar M
    FASEB J; 2004 Jul; 18(10):1111-3. PubMed ID: 15132990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphatic Vessel Network Structure and Physiology.
    Breslin JW; Yang Y; Scallan JP; Sweat RS; Adderley SP; Murfee WL
    Compr Physiol; 2018 Dec; 9(1):207-299. PubMed ID: 30549020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.